HSBC BANK PLC
CIK:0001140465|SEC Filings
Consolidated income statement - GBP (£) £ in Millions |
12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||||||||
| Profit or loss [abstract] | |||||||||||||
| Net interest expense | £ 985 | £ 2,151 | £ 1,904 | ||||||||||
| – interest income | [1],[2] | 19,414 | 17,782 | 6,535 | |||||||||
| – interest expense | [3] | (18,429) | (15,631) | (4,631) | |||||||||
| Net fee income/(expense) | 1,275 | 1,229 | 1,295 | ||||||||||
| – fee income | 2,758 | 2,594 | 2,593 | ||||||||||
| – fee expense | (1,483) | (1,365) | (1,298) | ||||||||||
| Net income from financial instruments held for trading or managed on a fair value basis | 4,726 | 3,395 | 2,875 | ||||||||||
| Net income/(expense) from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | 857 | 1,168 | (1,370) | ||||||||||
| Changes in fair value of long-term debt and related derivatives | 2 | (63) | 102 | ||||||||||
| Changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | 413 | 284 | 143 | ||||||||||
| Net gains/(losses) from financial investments | 22 | (84) | (60) | ||||||||||
| (Losses)/gains recognised on Assets held for sale | [4] | (100) | 296 | (1,947) | |||||||||
| Insurance finance (expense)/income | (984) | (1,184) | 1,106 | ||||||||||
| Insurance service result | 171 | 124 | 121 | ||||||||||
| – Insurance revenue | 398 | 379 | 361 | ||||||||||
| – Insurance service expense | (227) | (255) | (240) | ||||||||||
| Other operating income | 106 | 190 | 135 | ||||||||||
| Net operating income before change in expected credit losses and other credit impairment charges | [5] | 7,473 | 7,506 | 4,304 | |||||||||
| Change in expected credit losses and other credit impairment charges | (163) | (169) | (222) | ||||||||||
| Net operating income | 7,310 | 7,337 | 4,082 | ||||||||||
| Total operating expenses | (5,260) | (5,142) | (5,251) | ||||||||||
| – employee compensation and benefits | (1,672) | (1,706) | (1,698) | ||||||||||
| – general and administrative expenses | (3,440) | (3,375) | (3,425) | ||||||||||
| – depreciation and impairment of property, plant and equipment and right of use assets | (71) | (45) | (103) | ||||||||||
| – amortisation and impairment of intangible assets | (77) | (16) | (25) | ||||||||||
| Operating profit/(loss) | 2,050 | 2,195 | (1,169) | ||||||||||
| Share of profit/(loss) in associates and joint ventures | 18 | (43) | (30) | ||||||||||
| Profit/(loss) before tax | 2,068 | 2,152 | (1,199) | ||||||||||
| Tax (charge)/credit | (785) | (427) | 646 | ||||||||||
| Profit/(loss) for the year | 1,283 | 1,725 | (553) | ||||||||||
| Profit/(loss) attributable to the parent company | 1,253 | 1,703 | (563) | ||||||||||
| Profit attributable to non-controlling interests | £ 30 | £ 22 | £ 10 | ||||||||||
| |||||||||||||
Consolidated statement of cash flows - GBP (£) £ in Millions |
12 Months Ended | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||||||||||||||
| Cash flows from operating activities | |||||||||||||||||||
| Profit/(loss) before tax | £ 2,068 | £ 2,152 | £ (1,199) | ||||||||||||||||
| Adjustments for non-cash items | |||||||||||||||||||
| Depreciation, amortisation and impairment | 148 | 61 | 128 | ||||||||||||||||
| Net loss/(gain) from investing activities | [1] | 83 | (66) | 2,002 | |||||||||||||||
| Share of (profit)/loss in associates and joint ventures | (18) | 43 | 30 | ||||||||||||||||
| Change in expected credit losses gross of recoveries and other credit impairment charges | 165 | 161 | 253 | ||||||||||||||||
| Provisions including pensions | 78 | 132 | 192 | ||||||||||||||||
| Share-based payment expense | 61 | 58 | 46 | ||||||||||||||||
| Other non-cash items included in profit/(loss) before tax | (180) | (165) | (16) | ||||||||||||||||
| Elimination of exchange differences | [2] | 4,883 | 4,426 | (6,761) | |||||||||||||||
| Changes in operating assets and liabilities | (1,479) | (3,172) | 37,515 | ||||||||||||||||
| – change in net trading securities and derivatives | (13,266) | (15,528) | (6,213) | ||||||||||||||||
| – change in loans and advances to banks and customers | (455) | 4,245 | (2,717) | ||||||||||||||||
| – change in reverse repurchase agreements – non-trading | 9,341 | (13,531) | 6,251 | ||||||||||||||||
| – change in financial assets designated and otherwise mandatorily measured at fair value | (1,954) | (3,296) | 2,729 | ||||||||||||||||
| – change in other assets | 4,734 | (5,707) | (7,359) | ||||||||||||||||
| – change in deposits by banks and customer accounts | 14,113 | 7,548 | 19,835 | ||||||||||||||||
| – change in repurchase agreements – non-trading | (13,813) | 20,516 | 5,641 | ||||||||||||||||
| – change in debt securities in issue | 6,018 | 6,175 | (1,060) | ||||||||||||||||
| – change in financial liabilities designated at fair value | 4,937 | 4,042 | (1,827) | ||||||||||||||||
| – change in other liabilities | (10,026) | (7,506) | 21,393 | ||||||||||||||||
| – dividend received from associates | 0 | 15 | 7 | ||||||||||||||||
| – contributions paid to defined benefit plans | (20) | (5) | (10) | ||||||||||||||||
| – tax (paid)/received | (1,088) | (140) | 845 | ||||||||||||||||
| Net cash from operating activities | 5,809 | 3,630 | 32,190 | ||||||||||||||||
| Cash flows from investing activities | |||||||||||||||||||
| – purchase of financial investments | (32,587) | (26,586) | (13,227) | ||||||||||||||||
| – proceeds from the sale and maturity of financial investments | 23,272 | 15,497 | 20,490 | ||||||||||||||||
| – net cash flows from the purchase and sale of property, plant and equipment | (16) | (31) | (20) | ||||||||||||||||
| – net investment in intangible assets | (149) | (125) | (28) | ||||||||||||||||
| – net cash outflow from investment in associates and acquisition of businesses and subsidiaries | [3] | (955) | (1,161) | (29) | |||||||||||||||
| – net cash flow on disposal of subsidiaries, businesses, associates and joint ventures | [4] | (8,631) | (394) | 0 | |||||||||||||||
| Net cash from investing activities | (19,066) | (12,800) | 7,186 | ||||||||||||||||
| Cash flows from financing activities | |||||||||||||||||||
| – issue of ordinary share capital and other equity instruments | 2,782 | 584 | 628 | ||||||||||||||||
| – redemption of other equity instruments | (213) | 0 | 0 | ||||||||||||||||
| - subordinated loan capital issued | [5] | 2,777 | 3,246 | 3,111 | |||||||||||||||
| – subordinated loan capital repaid | [5] | (474) | (2,693) | (2,248) | |||||||||||||||
| – dividends to the parent company | (535) | (961) | (1,052) | ||||||||||||||||
| – funds received from the parent company | 0 | 0 | 1,465 | ||||||||||||||||
| – dividends paid to non-controlling interests | (11) | (7) | (2) | ||||||||||||||||
| Net cash from financing activities | 4,326 | 169 | 1,902 | ||||||||||||||||
| Net increase in cash and cash equivalents | (8,931) | (9,001) | 41,278 | ||||||||||||||||
| Cash and cash equivalents at 1 Jan | 177,037 | [6] | 189,907 | [6] | 140,923 | ||||||||||||||
| Exchange difference in respect of cash and cash equivalents | (5,178) | (3,869) | 7,706 | ||||||||||||||||
| Cash and cash equivalents at 31 Dec | [6] | 162,928 | 177,037 | 189,907 | |||||||||||||||
| Cash and cash equivalents comprise of | |||||||||||||||||||
| – cash and balances at central banks | 119,184 | 110,618 | 131,433 | ||||||||||||||||
| – loans and advances to banks of one month or less | 13,285 | 12,970 | 13,801 | ||||||||||||||||
| – reverse repurchase agreement with banks of one month or less | 15,908 | 28,704 | 23,182 | ||||||||||||||||
| – treasury bills, other bills and certificates of deposit less than three months | 143 | 144 | 294 | ||||||||||||||||
| – cash collateral, net settlement accounts and items in course of collection from/transmission to other banks | 12,783 | 16,323 | 19,272 | ||||||||||||||||
| - cash and cash equivalents held for sale | [7] | £ 1,625 | £ 8,278 | £ 1,925 | |||||||||||||||
| |||||||||||||||||||
Consolidated balance sheet - GBP (£) £ in Millions |
Dec. 31, 2024 |
Dec. 31, 2023 |
||||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash and balances at central banks | £ 119,184 | £ 110,618 | ||||
| Trading assets | 116,042 | 100,696 | ||||
| Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | 9,417 | 19,068 | ||||
| Derivatives | 198,172 | 174,116 | ||||
| Loans and advances to banks | 14,521 | 14,371 | ||||
| Loans and advances to customers | 82,666 | 75,491 | ||||
| Reverse repurchase agreements – non-trading | 53,612 | 73,494 | ||||
| Financial investments | 52,216 | 46,368 | ||||
| Assets held for sale | [1] | 21,606 | 20,368 | |||
| Prepayments, accrued income and other assets | [2] | 56,950 | 65,749 | |||
| Current tax assets | 1,043 | 485 | ||||
| Interests in associates and joint ventures | 703 | 665 | ||||
| Goodwill and intangible assets | 303 | 203 | ||||
| Deferred tax assets | 895 | 1,278 | ||||
| Total assets | 727,330 | 702,970 | ||||
| Liabilities | ||||||
| Deposits by banks | 26,515 | 22,943 | ||||
| Customer accounts | 242,303 | 222,941 | ||||
| Repurchase agreements – non-trading | 40,384 | 53,416 | ||||
| Trading liabilities | 42,633 | 42,276 | ||||
| Financial liabilities designated at fair value | 37,443 | 32,545 | ||||
| Derivatives | 197,082 | 171,474 | ||||
| Debt securities in issue | 19,461 | 13,443 | ||||
| Liabilities of disposal groups held for sale | [1] | 23,110 | 20,684 | |||
| Accruals, deferred income and other liabilities | [2] | 50,484 | 62,560 | |||
| Current tax liabilities | 250 | 272 | ||||
| Insurance contract liabilities | 3,424 | 20,595 | ||||
| Provisions | 275 | 390 | ||||
| Deferred tax liabilities | 5 | 6 | ||||
| Subordinated liabilities | 16,908 | 14,920 | ||||
| Total liabilities | 700,277 | 678,465 | ||||
| Equity | ||||||
| Total shareholders’ equity | 26,895 | 24,359 | ||||
| – called up share capital | 797 | 797 | ||||
| – share premium account | 3,582 | 1,004 | ||||
| – other equity instruments | 3,921 | 3,930 | ||||
| – retained earnings | 25,040 | 24,724 | ||||
| – other reserves | (6,445) | (6,096) | ||||
| Non-controlling interests | 158 | 146 | ||||
| Total equity | 27,053 | 24,505 | ||||
| Total liabilities and equity | £ 727,330 | £ 702,970 | ||||
| ||||||